Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer
Go back to Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 82.63 -2.48 (2.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.11 | 52 Week High | $8.22 | |||
| Open | $84.65 | 52 Week Low | $3.07 | |||
| Day High | $87.20 | P/E | N/A | |||
| Day Low | $82.16 | EPS | $-1.30 | |||
| Volume | 3,668,388 | |||||
